Women Health Online

Patients who take the diabetes drug metformin may be less likely to die over the course of 10 years than patients who take insulin secretagogues, a new study has found. The study of 107,806 diabetics found that patients who took secretagogues were 20 to 33 percent more likely to die over the course of the study than those who took the more commonly prescribed metformin. 

Similar Posts:

• Diabetes drug at 8 could shield girls from infertility
• Artificial Pancreas Helps Type 1 Diabetics
• Poor maternal nutrition predisposes offspring to type 2 diabetes
• New birth control pill ramps up blood clot risk: Study
• Women more likely to leave substance abuse treatment center after new tobacco-free policy